Professor Mike Sharland is a global expert in antimicrobial prescribing, resistance and healthcare associated infection in children, conducting strategic trials to inform policy.
Professor Mike Sharland is a leading global expert in the prevention and treatment of multi drug resistant infections in children.
He has previously chaired the Department of Health’s Expert Advisory Body on antimicrobial prescribing resistance and healthcare associated infection (APRHAI).
He now Chair's the WHO Essential Medicine List Antibiotic Working Group, that developed the AWaRe system and has produced the WHO Antibiotic Book providing global guidance on antibiotic prescribing for 35 infections in adults and children.
He co-chairs PENTA-ID, the EMA Level 1 recognised clinical trials network on antimicrobials in Europe. PENTA-ID conducts strategic trials focussing on the optimal use of antibiotics and infection prevention and control.
He has developed the Paediatric Infectious Diseases Unit at St George’s into a recognised Centre of excellence for clinical care, teaching and research. He was appointed Professor of Paediatric Infectious Diseases in November 2010.
Professor Sharland’s principal research interest is optimising the best use of antimicrobials in children. He has a long standing interest in developing the evidence base for the use of all paediatric antimicrobials and has developed a clear research strategy using both cohort studies and clinical trials to improve the evidence base for antimicrobial prescribing. He leads a wide number of global clinical observational and interventional trials, many conducted in collaboration with the the Global Research and Development Partnership.